11 September 2024
Forbion Leads $14m Series A in SOLASTA Bio to advance development and commercialisation of first-in-class sustainable crop protection solutions
Forbion Leads $14m Series A in SOLASTA Bio
Joy Faucher, Partner at Forbion for its BioEconomy Fund noted, “As traditional insect control agents struggle with resistance and impact to biodiversity, SOLASTA’s demonstrated cost-effective, sustainable and high-efficacy solution is poised to transform the crop protection market. We are excited to support SOLASTA in continuing the development and commercialisation of its first-in-class peptide products.”
“We have come a long way since setting out on this journey 3 years ago. We have developed our unique technology platform to address grower pain points, have expanded operations to the US and have brough together outstanding competencies in technology and agribusiness. The results of our field trials have been hugely encouraging, demonstrating high efficacy of biopeptides against target insect pests, as effective or better than standard insecticides” said Shireen Davies PhD, FRSE, CEO and co-founder, SOLASTA Bio. “With the Series A, it’s time for SOLASTA Bio to kick on to the next level and successfully hit our targets for commercialisation.”
More articles
11 September 2024
Business Insider – SOLASTA’s Series A Investment
Business Insider, 11th September 2024 https://www.businessinsider.com/solasta-bio-agriculture-biohealth-startup-raises-vc-funding-2024-9 "Solasta was founded based on fundamental research carried out by our team to understand how insects survive and how we could push select insects out without ...
11 September 2024
SOLASTA Bio completes Series A investment round with $14m
We've just completed an oversubscribed $14M Series A funding round to accelerate our nature-inspired crop protection technology. This milestone marks a significant step forward in our mission to revolutionise the global ...